Upstream / Downstream

pathwayImage

Explore pathways related to this product.

Friends and Family

25% Off

the purchase of 3 or more products

Shop

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

We recommend the following alternatives

W IP         H M R
REACTIVITY SENSITIVITY MW (kDa) SOURCE
45 Rabbit

Product Usage Information

Storage: Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. Store at –20°C. Do not aliquot the antibody.

Specificity / Sensitivity

Phospho-MEK1 (Thr292) Antibody recognizes endogenous levels of MEK1 protein only when phosphorylated at Thr292. This antibody does not cross-react with MEK2 protein. This antibody cross-reacts with a 170 kDa protein of unknown identity in some cell lysates.


Species predicted to react based on 100% sequence homology: Dog, Pig

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr292 of human MEK1 protein. Antibodies are purified by protein A and peptide affinity chromatography.

MEK1 and MEK2, also called MAPK or Erk kinases, are dual-specificity protein kinases that function in a mitogen activated protein kinase cascade controlling cell growth and differentiation (1-3). Activation of MEK1 and MEK2 occurs through phosphorylation of two serine residues at positions 217 and 221, located in the activation loop of subdomain VIII, by Raf-like molecules. MEK1/2 is activated by a wide variety of growth factors and cytokines and also by membrane depolarization and calcium influx (1-4). Constitutively active forms of MEK1/2 are sufficient for the transformation of NIH/3T3 cells or the differentiation of PC-12 cells (4). MEK activates p44 and p42 MAP kinase by phosphorylating both threonine and tyrosine residues at sites located within the activation loop of kinase subdomain VIII.


In response to integrin signaling, p21-activated kinase -1 (PAK-1) phosphorylates MEK1 at Ser298, which enhances MEK1-ERK2 complex formation and MEK1 activation by Raf-1. These events positively regulate the Raf-1-MEK-ERK signaling cascade (5-9). Research studies have identified a negative regulatory loop in the Raf-1-MEK-ERK signaling cascade, in which ERK2-dependent phosphorylation of MEK1 at Thr292 negatively regulates MEK1 activation following cell adhesion. Specifically, ERK2-dependent phosphorylation of MEK1 also attenuates its PAK-1-mediated phosphorylation, contributing to a reduction in Raf-dependent phosphorylation of residues within the MEK1 activation loop (7,10).


1.  Crews, C.M. et al. (1992) Science 258, 478-480.

2.  Alessi, D.R. et al. (1994) EMBO J. 13, 1610-19.

3.  Rosen, L.B. et al. (1994) Neuron 12, 1207-21.

4.  Cowley, S. et al. (1994) Cell 77, 841-52.

5.  Frost, J.A. et al. (1997) EMBO J 16, 6426-38.

6.  Rossomando, A.J. et al. (1994) Mol Cell Biol 14, 1594-602.

7.  Eblen, S.T. et al. (2004) Mol Cell Biol 24, 2308-17.

8.  Eblen, S.T. et al. (2002) Mol Cell Biol 22, 6023-33.

9.  Coles, L.C. and Shaw, P.E. (2002) Oncogene 21, 2236-44.

10.  Xu, B.e. et al. (1999) J Biol Chem 274, 34029-35.


Entrez-Gene Id 5604
Swiss-Prot Acc. Q02750


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
XP is a registered trademark of Cell Signaling Technology, Inc.
Tween is a registered trademark of ICI Americas, Inc.

51265
Phospho-MEK1 (Thr292) Antibody